Update: Implementation of a multidisciplinary quality improvement initiative to improve molecular testing rates in advanced non-squamous non-small cell lung cancer.

被引：0
|
作者：
Otaibi, Zachary
Kamran, Amir
Finley, Gene Grant
White, Richard
Colonias, Athanasios
Weksler, Benny
Wegner, Rodney E.
机构：
[1] Allegheny Hlth Network, Pittsburgh, PA USA
[2] Allegheny Hlth Network, Canc Inst, Pittsburgh, PA USA
[3] Allegheny Gen Hosp, Sewickley, PA USA
[4] Allegheny Hlth Network, Dept Cardiothorac Surg, Pittsburgh, PA USA
[5] Allegheny Hlth Network, Canc Inst, Div Radiat Oncol, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e18085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18085
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Molecular testing in non-small cell lung cancer
    Mahmood, Bayan
    Yin, Su Lei
    Muhammad, SyedAun
    Dancey, Gairin
    Medeiros, Filomena
    [J]. LUNG CANCER, 2022, 165 : S35 - S35
  • [42] Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
    Minami, Seigo
    Kijima, Takashi
    [J]. LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 13 - 25
  • [43] The utility of transbronchial rebiopsy for peripheral pulmonary lesions in patients with advanced non-squamous non-small cell lung cancer
    Tateishi, Akiko
    Matsumoto, Yuji
    Tanaka, Midori
    Nakai, Toshiyuki
    Sasada, Shinji
    Aoshima, Masahiro
    Tsuchida, Takaaki
    [J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [44] Pemetrexed(P) in Third and Fourth Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (Non-Squamous)-aNSCLCns
    Grigorescu, Alexandru Calin
    Ilie, Dan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S929 - S929
  • [45] Meta-Analysis of Metformin in Combination with Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
    Marrone, K.
    Parikh, A.
    Becker, D.
    Brahmer, J.
    Ettinger, D.
    Levy, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S894 - S894
  • [46] Camrelizumab in patients with advanced non-squamous non-small cell lung cancer: a cost-effective analysis in China
    Xie, Qian
    Zheng, Hanrui
    Su, Na
    Li, Qiu
    [J]. BMJ OPEN, 2022, 12 (08):
  • [47] ADVERSE EFFECTS IN COMBINATION THERAPY WITH BEVACIZUMAB IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER - RETROSPECTIVE STUDY
    Cerna, Maria
    Berzinec, Peter
    Kasan, Peter
    Chowaniecova, Gabriela
    Martak, Marian
    Vesela, Milada
    Jancokova, Iveta
    Kuliskova, Iveta
    Mazal, Juraj
    Kavcova, Elena
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1199 - S1199
  • [48] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
    Waples, J. M.
    Auerbach, M.
    Boccia, R.
    Wiggans, R. G.
    Steis, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    Kawano, Yuko
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Tanimoto, Azusa
    Nishizawa, Hironari
    Ichikawa, Atsuo
    Sakatani, Toshio
    Nakatomi, Katsumi
    Hagiwara, Sachiko
    Ninomiya, Hironori
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    [J]. ANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333
  • [50] Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
    Suzanne McMullen
    Lisa M. Hess
    Edward S. Kim
    Benjamin Levy
    Mohamed Mohamed
    David Waterhouse
    Antoinette Wozniak
    Sarah Goring
    Kerstin Müller
    Catherine Muehlenbein
    Himani Aggarwal
    Yajun Zhu
    Ana B. Oton
    Jennifer L. Ersek
    Katherine B. Winfree
    [J]. The Patient - Patient-Centered Outcomes Research, 2019, 12 : 223 - 233
12345